Oct 28, 2026 09:41AM
Oct 28, 2026 09:40AM
Oct 28, 2026 09:40AM
Oct 5, 2026 02:54PM
Jul 23, 2026 04:00PM
Jul 23, 2026 04:00PM
Jul 13, 2026 06:36AM H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)
Jul 2, 2026 06:41AM
Jun 11, 2026 10:46AM
Jun 11, 2026 10:45AM
Feb 23, 2026 06:28AM
Feb 17, 2026 11:01AM
Jan 28, 2026 06:42AM
Jan 20, 2026 06:39AM Genmab A/S (GMAB) PT Lowered to $39 at H.C. Wainwright
Dec 8, 2025 04:15AM
Dec 7, 2025 07:50AM
Dec 7, 2025 07:50AM
Dec 7, 2025 07:50AM
Dec 7, 2025 07:50AM
Nov 18, 2025 11:30AM
Nov 18, 2025 11:30AM Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Ly
Nov 10, 2025 06:48AM
Nov 6, 2025 11:02AM
Nov 3, 2025 09:05AM
Oct 18, 2025 06:00AM
Sep 29, 2025 01:08AM
Sep 29, 2025 01:08AM
Sep 3, 2025 08:30AM Genmab reports 92% outpatient dosing rate in lymphoma drug trial
Sep 3, 2025 08:30AM
Aug 19, 2025 08:01AM
Aug 19, 2025 08:00AM
Aug 15, 2025 06:51AM
Aug 7, 2025 11:08AM
Aug 7, 2025 10:30AM
Aug 7, 2025 10:30AM Genmab's epcoritamab combo meets Phase 3 trial goals in lymphoma
Aug 7, 2025 10:30AM
Aug 7, 2025 10:30AM
May 1, 2025 08:24PM
May 1, 2025 08:14PM
Mar 17, 2025 12:19PM
Mar 17, 2025 12:19PM
Feb 12, 2025 11:01AM Genmab Publishes 2024 Annual Report
Dec 21, 2024 10:00AM
Dec 7, 2024 07:00PM
Sep 20, 2024 06:48AM
Sep 15, 2024 08:45AM
Aug 8, 2024 11:03AM
Jun 27, 2024 06:37AM
Jun 27, 2024 05:08AM Genmab A/S (GMAB) PT Raised to $47 at BTIG
Jun 26, 2024 07:03PM

336,148 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All